No news there but comforting that boxes keep getting ticked.
Cash burn is slower than you might think for this sort of company.
I think the most interesting thing is this debt facility. I love that they are cognisant of shaeholder dilution with equity capital raises. Says that they are totally aligned with us.
I've been burned a few times on bio techs/device companies but I have a strong feeling that this one might be the business.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-2
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EBR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.000(0.00%) |
Mkt cap ! $354.3M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 908 | $1.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.15 | 26139 | 3 |
View Market Depth
| Last trade - 09.29am 16/08/2024 (20 minute delay) ? |
| EBR (ASX) Chart |
Day chart unavailable